IPO - Oncology Institute, Inc.

Form Type: S-3

Filing Date: 2025-05-08

Corporate Action: Ipo

Type: New

Accession Number: 000107997325000775

Filing Summary: On May 8, 2025, The Oncology Institute, Inc. filed a registration statement on Form S-3 with the Securities and Exchange Commission. This filing enables the resale of up to 27,924,611 shares of its common stock by identified selling securityholders. The common stock is considered a part of a 'shelf' registration process allowing for continuous or delayed sales. The shares consist of previously issued and outstanding stock, pre-funded warrants, and common warrants, which can be exercised for additional shares. The company will not receive proceeds from resale but expects to receive around $11.2 million from cash exercises of the warrants. The last reported sale price of their common stock prior to the filing was $2.75 per share. They have identified themselves as an emerging growth company and a smaller reporting company. The comprehensive nature of the registration statement outlines the terms of the offering, the rights of shareholders, and various risk factors associated with investing in the company’s securities. The document includes necessary information about the company's operations, management services, and the context for the current offering, solidifying its positioning within the oncology sector.